Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026

Same author

[2025 Clinical practice guidelines of the Mexican Society of Heart Care (SOMECCOR) and the Mexican Society of Cardiology (SMC) on cardiovascular rehabilitation and prevention: therapeutic exercise training and heart-healthy lifestyle. Executive summary].

Archivos de cardiologia de Mexico·2026

Same author

Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.

Archivos de cardiologia de Mexico·2025

Same author

Latin-American guidelines of recommendations at discharge from an acute coronary syndrome.

Archivos de cardiologia de Mexico·2024

Same author

The rescue of medical education crippled by the COVID-19 pandemic.

Archivos de cardiologia de Mexico·2024

Same author

Mexican positioning statement for the preparticipation screening and cardiovascular evaluation in athletes.

Archivos de cardiologia de Mexico·2023

Search research articles

Related Experiment Video

Updated: May 28, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

[Therapeutic adherence].

Rafael César Chávez-Domínguez¹, Hermes Ilarraza-Lomeli, Jorge Gaspar-Hernández

¹Departamento de Epidemiología.

Archivos De Cardiologia De Mexico

|October 7, 2011

Summary

This summary is machine-generated.

Improving chronic cardiovascular disease treatment adherence requires broad collaboration beyond the doctor-patient relationship. Community action, health culture promotion, and modernizing healthcare are key to resolving this global public health issue.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Cardiology
Public Health
Social Medicine

Context:

Chronic cardiovascular disease treatment non-adherence is a significant global clinical and public health challenge.
The issue extends beyond the traditional doctor-patient dynamic, necessitating a broader societal approach.
The Mexican Society of Cardiology recognizes its pivotal role in addressing this complex problem.

Purpose:

To review existing literature on cardiovascular disease treatment adherence.
To present findings from a qualitative research study involving organized discussions at the Congress of Cardiology.
To explore strategies for improving adherence through collaboration and community action.

Summary:

The study highlights the multifaceted nature of cardiovascular disease treatment non-adherence.
It emphasizes the need for organized community action, involving healthcare providers, patients, and facilities.
Key recommendations include fostering a health culture and revitalizing the doctor-patient relationship.

Impact:

Provides an initial report and qualitative insights into a critical healthcare issue.
Stresses the importance of interdisciplinary collaboration for effective public health interventions.
Advocates for adapting medical practices to contemporary societal demands and changes.